A 40-year-old man presents with productive cough for 3 months. Two sputum smears are AFB negative. Xpert MTB/RIF Ultra is performed and reports MTB detected (very low) with rifampicin indeterminate. What is the clinical interpretation and next step?
- A AFB-negative result overrides the Xpert result; treat as non-TB
- B Rifampicin resistance confirmed; start MDR-TB regimen immediately
- C MTB likely present at very low bacillary load; rifampicin susceptibility cannot be determined — send for culture and LPA/DST ✓
- D Very low result indicates contamination; repeat Xpert on new sample only
Explanation
Xpert MTB/RIF Ultra reports five semi-quantitative MTB detection levels (very high to very low/trace); a 'very low/trace' call means MTB DNA detected at threshold levels (sensitivity improved over original Xpert but specificity slightly lower at very low calls). 'Rifampicin indeterminate' indicates the probe signals are borderline — insufficient to confidently determine rpoB mutation status. The correct response per WHO guidelines is to accept MTB detection as probable TB and simultaneously send a second specimen for culture and phenotypic DST and/or line probe assay to clarify rifampicin susceptibility before committing to MDR-TB regimen.
Reference: Ananthanarayan & Paniker's Textbook of Microbiology, 11th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.